Mode
Text Size
Log in / Sign up
Phase 2 Completed N=26 Randomized Treatment

Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

Acute Wounds
Source: ClinicalTrials.gov NCT00816101 ↗
Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Mar 2011
Primary outcomePrimary: Number of Patients Who Experienced 50% or Greater Wound Healing — 13; 7; 4 Participants

Summary

The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesiccation of skin lesions.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients Who Experienced 50% or Greater Wound Healing
13; 7; 4
SECONDARY
Number of Patients Reporting Pain
0; 0; 0
SECONDARY
Erythema at Week 3
0.45; 1.29; 0.60

Eligibility Criteria

Inclusion Criteria

If female, must either be not of childbearing potential or if they are of childbearing potential must have a negative urine pregnancy test.

  • Wound size greater than 1x1 cm
  • Wounds must be ≥5 cm away from all other wounds
  • Wound size must not be diminished in size greater than 10% between enrollment in study and the prescreening
  • Participant agrees to participate in follow-up evaluation
  • Participant must be able to read and understand informed consent, and sign the informed consent

Exclusion Criteria

  • Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study
  • Participant is to receive another topical antimicrobial agent other than the study dressing
  • Participant with sensitivity or adverse reactions to silver or zinc
  • Pregnancy or nursing an infant or child
  • Immunosuppression
  • Active or systemic infection
  • Peripheral vascular occlusive disease
  • Collagen vascular disease
  • Connective tissue disease
  • Diabetes
  • Venous stasis ulcers
  • Participant undergoing active cancer chemotherapy
  • Chronic steroid use
  • Decision impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00816101). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search